Excellence in Single Domain Biotherapeutics
Isogenica develops therapeutic VHH:
highly versatile small format antibodies which are used to construct next generation biotherapeutics for the treatment of cancer, inflammation and other serious diseases.
Our VHH can be assembled to create bi-specific and multi-specific biotherapeutics for your target profile, or used to achieve targeted drug delivery as components of ADCs and cell and gene therapies including CAR-Ts.
Synthetic libraries for faster discovery
At diversities of 1010 – 1013, Isogenica’s VHH libraries are the most diverse synthetic VHH libraries on the market. Typically, leads from Isogenica’s synthetic libraries have low nanomolar affinities, which are optimal for your drug development needs… read more about our libraries.
Isogenica’s partnerships with global biopharmaceutical companies have resulted in a deep pipeline with three clinical partnered assets, including one clinical Phase II asset and eleven partnered pre-clinical and discovery programs.
Isogenica works with partners through collaborative research and commercial licenses to further develop proprietary LlamdA® VHH or to discover novel LlamdA® VHH as direct therapeutics and targeting agents. Contact us today to see how we can work together with you to discover and develop your VHH solutions.
News & Events
Isogenica renews collaboration with the Royal Academy of Engineering to support students from under-represented groups
We are delighted to be working with the Royal Academy of Engineering as part of their Graduate Engineering Engagement Programme (GEEP).
As the year draws to a close, we have been reflecting on the events at Isogenica over the last quarter. We’ve had a busy few months….
Isogenica announces two Pioneering Collaborations with an Antibody Research and License Agreement, and an Asset Evaluation Deal
Isogenica, a leading innovator in VHH antibodies, is proud to unveil two significant collaborations, demonstrating the company’s commitment to advancing healthcare through cutting-edge research and development.
Careers at Isogenica
A career at Isogenica provides an opportunity to lead, execute or support the commercial development of next generation biotherapeutics.